Tag: phase III
SARAH study results to be presented as oral abstract at April...
Sirtex has announced that the SARAH (Sorafenib vs. radioembolisation in advanced hepatocellular carcinoma) randomised controlled study results will be presented at the upcoming European...
Ulipristal acetate first oral therapy to show positive phase III results...
Ulipristal acetate is the first oral therapy to demonstrate efficacy and safety for uterine fibroids in two US pivotal studies, a press release states.
Allergan...
